These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 24899407
21. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC. Cancer Res; 2013 Sep 01; 73(17):5580-90. PubMed ID: 23832667 [Abstract] [Full Text] [Related]
22. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J. Oncol Rep; 2013 Sep 01; 30(3):1309-14. PubMed ID: 23828071 [Abstract] [Full Text] [Related]
23. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ. Oncotarget; 2016 Jan 26; 7(4):4279-97. PubMed ID: 26701853 [Abstract] [Full Text] [Related]
24. WWOX induces apoptosis and inhibits proliferation in cervical cancer and cell lines. Qu J, Lu W, Li B, Lu C, Wan X. Int J Mol Med; 2013 May 26; 31(5):1139-47. PubMed ID: 23525362 [Abstract] [Full Text] [Related]
25. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P. Cell Death Differ; 2007 Jun 26; 14(6):1202-10. PubMed ID: 17347668 [Abstract] [Full Text] [Related]
26. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu XT, Chen Q, Zhao YM, Zhu K, Yu L, Yang GH, Wang Z, Wu WZ, Zhou J, Fan J. J Pathol; 2014 Nov 26; 234(3):316-28. PubMed ID: 24962955 [Abstract] [Full Text] [Related]
27. The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. Aderca I, Moser CD, Veerasamy M, Bani-Hani AH, Bonilla-Guerrero R, Ahmed K, Shire A, Cazanave SC, Montoya DP, Mettler TA, Burgart LJ, Nagorney DM, Thibodeau SN, Cunningham JM, Lai JP, Roberts LR. J Hepatol; 2008 Sep 26; 49(3):373-83. PubMed ID: 18620777 [Abstract] [Full Text] [Related]
28. Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma. Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M. Int J Clin Exp Pathol; 2014 Sep 26; 7(3):987-95. PubMed ID: 24696716 [Abstract] [Full Text] [Related]
29. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ. Mol Pharmacol; 2013 May 26; 83(5):1109-19. PubMed ID: 23478801 [Abstract] [Full Text] [Related]
32. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells. Yan H, Tong J, Lin X, Han Q, Huang H. Mol Med Rep; 2015 Aug 26; 12(2):1783-8. PubMed ID: 25891642 [Abstract] [Full Text] [Related]
34. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A. Cancer Gene Ther; 2010 Apr 26; 17(4):275-88. PubMed ID: 19876077 [Abstract] [Full Text] [Related]
35. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma. Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL. Ann Surg Oncol; 2013 Nov 26; 20(12):4041-54. PubMed ID: 22911364 [Abstract] [Full Text] [Related]
36. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. Geng D, Zhao W, Feng Y, Liu J. Tumour Biol; 2016 Mar 26; 37(3):3341-7. PubMed ID: 26443539 [Abstract] [Full Text] [Related]
37. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R. Carcinogenesis; 2014 Feb 26; 35(2):461-8. PubMed ID: 24104553 [Abstract] [Full Text] [Related]
38. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L, Xi-Ran Z. Hepatogastroenterology; 2004 Feb 26; 51(56):515-25. PubMed ID: 15086194 [Abstract] [Full Text] [Related]
39. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST. Carcinogenesis; 2008 Nov 26; 29(11):2096-105. PubMed ID: 18765415 [Abstract] [Full Text] [Related]
40. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Mahajan NP, Whang YE, Mohler JL, Earp HS. Cancer Res; 2005 Nov 15; 65(22):10514-23. PubMed ID: 16288044 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]